Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
TransAlta Corporation (TSX:TA) (NYSE:TAC) ("TransAlta" or the "Company") and The Mangrove Partners Master Fund, Ltd. ("Mangrove") announced today that the parties have agreed to resolve this